| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $650.6M | +0.5% |
| Cost of Revenue | $154.1M | +3.8% |
| Gross Profit | $496.5M | -0.5% |
| R&D Expense | $146.1M | -7.1% |
| SG&A Expense | $74.3M | +0.0% |
| Operating Income | $248.6M | +4.1% |
| Pre-tax Income | $294.8M | +8.3% |
| Income Tax | $52.7M | +5.3% |
| Net Income | $242.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138.4M | +39.8% |
| Short-term Investments | $464.0M | +17.9% |
| Accounts Receivable | $120.0M | +5.5% |
| Inventory | $240.9M | +31.7% |
| Current Assets | $1.09B | +20.8% |
| Total Assets | $1.96B | +7.2% |
| Current Liabilities | $108.0M | -13.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $210.8M | -16.9% |
| Capital Expenditures | $56.5M | +32.4% |
| Investing Cash Flow | -$45.5M | +72.3% |
| Financing Cash Flow | -$126.0M | -53.0% |
| Free Cash Flow | $154.4M | -26.9% |
| +9.0% |
| EPS (Basic) | $5.09 | +9.2% |
| EPS (Diluted) | $5.08 | +9.2% |
| Total Liabilities |
| $202.7M |
| -6.1% |
| Stockholders' Equity | $1.76B | +8.9% |